Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kobayashi Pharmaceutical Co's quarterly common stock
stayed the same
from Jun. 2025 (円3,450 Mil) to Sep. 2025 (円3,450 Mil) and
stayed the same
from Sep. 2025 (円3,450 Mil) to Dec. 2025 (円3,450 Mil).
Kobayashi Pharmaceutical Co's annual common stock
stayed the same
from Dec. 2023 (円3,450 Mil) to Dec. 2024 (円3,450 Mil) and
stayed the same
from Dec. 2024 (円3,450 Mil) to Dec. 2025 (円3,450 Mil).
Kobayashi Pharmaceutical Co Common Stock Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kobayashi Pharmaceutical Co (TSE:4967) has a Common Stock of 円3,450 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Kobayashi Pharmaceutical Co and its competitors.
Is Kobayashi Pharmaceutical Co's Common Stock too high?
Kobayashi Pharmaceutical Co's current Common Stock is 円3,450 Mil. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's Common Stock compare to PG and CL?
Kobayashi Pharmaceutical Co's Common Stock of 円3,450 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Consumer Packaged Goods company?
A good Common Stock depends on the Consumer Packaged Goods industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Kobayashi Pharmaceutical Co and its competitors. Kobayashi Pharmaceutical Co's current Common Stock is 円3,450 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co (TSE:4967) is currently considered Fairly Valued. The stock's GF Value™ is 円5,758.66, compared to a current price of 円5,497.00 — trading 4.5% below its estimated fair value. The current Common Stock is 円3,450 Mil. Kobayashi Pharmaceutical Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (TSE:4967), the current Common Stock is 円3,450 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kobayashi Pharmaceutical Co (TSE:4967) Overvalued in 2026?
Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be undervalued.
The current stock price of 円5,497.00 is trading 4.5% below its estimated GF Value™ of 円5,758.66.
GuruFocus considers Kobayashi Pharmaceutical Co to be Fairly Valued.
Key valuation signals for TSE:4967:
Common Stock: 円3,450 Mil
GF Value™: 円5,758.66 vs. price of 円5,497.00 (4.5% below fair value)
No single metric tells the full story. See the TSE:4967 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
81GF Score
Get the complete analysis for TSE:4967
Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4967 has been successfully added to your 
